| |
| |
|
| Insider
Information: |
Spangler Patrick D |
| Relationship: |
Director |
| City: |
Plymouth |
| State: |
MN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
177,377 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$16 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
177,377 |
|
|
| Total
Value |
$16 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Urologix Inc |
ULGX |
Director |
2014-11-06 |
155,257 |
2010-11-09 |
0 |
Premium* |
|
|
Optimizerx Corporation |
OPRX |
Director |
2023-06-07 |
22,120 |
2018-06-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OPRX |
Optimizerx Corporation |
Director |
– • – |
2023-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,637 |
22,120 |
0 |
- |
|
| OPRX |
Optimizerx Corporation |
Director |
– • – |
2022-12-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
409 |
16,826 |
0 |
- |
|
| OPRX |
Optimizerx Corporation |
Director |
– • – |
2022-09-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
334 |
16,417 |
0 |
- |
|
| OPRX |
Optimizerx Corporation |
Director |
– • – |
2021-11-11 |
4 |
AS |
$84.38 |
$527,544 |
D/D |
(6,252) |
16,083 |
0 |
- |
|
| OPRX |
Optimizerx Corporation |
Director |
– • – |
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
407 |
22,335 |
0 |
- |
|
| OPRX |
Optimizerx Corporation |
Director |
– • – |
2021-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
539 |
21,928 |
0 |
- |
|
| OPRX |
Optimizerx Corporation |
Director |
– • – |
2020-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
802 |
21,389 |
0 |
- |
|
| OPRX |
Optimizerx Corporation |
Director |
– • – |
2020-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,183 |
20,587 |
0 |
- |
|
| OPRX |
Optimizerx Corporation |
Director |
– • – |
2020-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,937 |
19,404 |
0 |
- |
|
| OPRX |
Optimizerx Corporation |
Director |
– • – |
2020-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,784 |
17,467 |
0 |
- |
|
| OPRX |
Optimizerx Corporation |
Director |
– • – |
2020-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,084 |
14,683 |
0 |
- |
|
| OPRX |
Optimizerx Corporation |
Director |
– • – |
2019-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,084 |
12,599 |
0 |
- |
|
| OPRX |
Optimizerx Corporation |
Director |
– • – |
2019-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,084 |
6,347 |
0 |
- |
|
| OPRX |
Optimizerx Corporation |
Director |
– • – |
2018-10-08 |
4 |
B |
$0.00 |
$0 |
D/D |
2,084 |
4,263 |
2.31 |
- |
|
| OPRX |
Optimizerx Corporation |
Director |
– • – |
2018-06-29 |
4 |
B |
$0.00 |
$0 |
D/D |
2,084 |
2,179 |
2.31 |
- |
|
| OPRX |
Optimizerx Corporation |
Director |
– • – |
2018-06-27 |
4 |
B |
$9.95 |
$945 |
D/D |
95 |
95 |
2.31 |
- |
|
| ULGX |
Urologix Inc |
Director |
– • – |
2014-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
45,455 |
155,257 |
0 |
- |
|
| ULGX |
Urologix Inc |
Director |
– • – |
2013-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
109,802 |
0 |
- |
|
| ULGX |
Urologix Inc |
Director |
– • – |
2012-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
26,516 |
59,802 |
0 |
- |
|
| ULGX |
Urologix Inc |
Director |
– • – |
2011-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
18,042 |
33,286 |
0 |
- |
|
| ULGX |
Urologix Inc |
Director |
– • – |
2010-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
15,244 |
15,244 |
0 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
